Storage results 2012

January 10, 2013 Group News

Cryo-Save Group N.V. (Euronext: CRYO, ‘Cryo-Save’, or ‘the Group’), the leading international stem cell storage company and the largest family stem cell bank in Europe, stored 35,100 new samples in 2012 (2011: 39,900 new samples).


  • 8,300 new samples stored in Q4 2012 (Q4 2011:10,300). Of these, 4,900 were new cord blood samples and 3,400 new cord tissue samples.
  • 35,100 new samples stored in 2012 (2011:39,900). Of these, 21,200 were new cord blood samples and 13,900 new cord tissue samples.
  • 239,000 samples have been stored in total at 31 December 2012.


Arnoud van Tulder, Chief Executive officer, commented:

We are pleased to report a 35% storage growth in India compared to previous year. This is an immediate result from measures we implemented in India. At this point in time this considerable growth in one of our very promising markets does not compensate the significant decline in Southern Europe, predominantly Spain.

We are convinced that 2013 will be a turn-around year to regain profitable growth, as we continue to implement measures that focus on our current markets and core services.


Cryo-Save Group + 31 (0) 575 509 100
Arnoud van Tulder, Chief Executive Officer

Daniel Stewart & Company plc (UK) + 44 (0) 20 7776 6550
Martin Lampshire

Free footage is available on

Related Articles